{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:56:59Z","timestamp":1790312219697,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Korea Health Technology R&D Project"},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI15C1799"],"award-info":[{"award-number":["HI15C1799"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2009-0081674,5"],"award-info":[{"award-number":["NRF-2009-0081674,5"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.neuint.2017.11.006","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T19:18:38Z","timestamp":1511205518000},"page":"96-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220"],"prefix":"10.1016","volume":"112","author":[{"given":"Ji Ae","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nari","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Young","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Duk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyou","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2017.11.006_bib1","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","article-title":"Oxidative DNA damage in the Parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra","volume":"69","author":"Alam","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2017.11.006_bib2","doi-asserted-by":"crossref","first-page":"33855","DOI":"10.1074\/jbc.274.48.33855","article-title":"Degradation of alpha-synuclein by proteasome","volume":"274","author":"Bennett","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.11.006_bib3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuro.2006.07.019","article-title":"In\u00a0vivo modulation of the parkinsonian phenotype by Nrf2","volume":"27","author":"Burton","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2017.11.006_bib4","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1073\/pnas.0813361106","article-title":"Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuint.2017.11.006_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12640-009-9078-1","article-title":"Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3","volume":"16","author":"Cho","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuint.2017.11.006_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","article-title":"Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease?","volume":"25","author":"Chu","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2017.11.006_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1146\/annurev.bi.65.070196.004101","article-title":"Structure and functions of the 20S and 26S proteasomes","volume":"65","author":"Coux","year":"1996","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuint.2017.11.006_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuint.2017.11.006_bib9","doi-asserted-by":"crossref","first-page":"e73710","DOI":"10.1371\/journal.pone.0073710","article-title":"Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer","volume":"8","author":"Cron","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2017.11.006_bib10","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3892\/mmr.2015.4657","article-title":"Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt\/Nrf2 pathway","volume":"13","author":"Cui","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuint.2017.11.006_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0300-9084(01)01250-0","article-title":"Degradation of oxidized proteins by the 20S proteasome","volume":"83","author":"Davies","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.neuint.2017.11.006_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1471-4159.1998.70010268.x","article-title":"Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay","volume":"70","author":"Floor","year":"1998","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2017.11.006_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mam.2008.08.009","article-title":"Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase","volume":"30","author":"Franklin","year":"2009","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.neuint.2017.11.006_bib14","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.neuint.2017.11.006_bib15","doi-asserted-by":"crossref","first-page":"e85305","DOI":"10.1371\/journal.pone.0085305","article-title":"n-butylidenephthalide protects against dopaminergic neuron degeneration and \u03b1-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease","volume":"9","author":"Fu","year":"2014","journal-title":"PLos One"},{"key":"10.1016\/j.neuint.2017.11.006_bib16","doi-asserted-by":"crossref","first-page":"17775","DOI":"10.1523\/JNEUROSCI.3049-12.2012","article-title":"Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model","volume":"32","author":"Gan","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.11.006_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000322532","article-title":"In\u00a0vitro biotransformation, in\u00a0vivo efficacy and pharmacokinetics of antimalarial chalcones","volume":"87","author":"Gutteridge","year":"2011","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuint.2017.11.006_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2013.05.036","article-title":"Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydroxydopamine-lesioned rats as models of Parkinson's disease: reciprocal up-regulation of E6-AP and down-regulation of \u03b1-synuclein","volume":"1524","author":"Ham","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2017.11.006_bib19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/jnr.20974","article-title":"Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway","volume":"84","author":"Hara","year":"2006","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuint.2017.11.006_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10863-009-9257-z","article-title":"The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease","volume":"41","author":"Hastings","year":"2009","journal-title":"J.\u00a0Bioenerg. Biomembr."},{"key":"10.1016\/j.neuint.2017.11.006_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","article-title":"Role of oxidative stress in Parkinson's disease","volume":"22","author":"Hwang","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.neuint.2017.11.006_bib22","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.febslet.2008.06.045","article-title":"The coffee diterpene kahweol induces heme oxygenase-1 via the PI3K and p38\/Nrf2 pathway to protect human dopaminergic neurons from 6-hydroxydopamine-derived oxidative stress","volume":"582","author":"Hwang","year":"2008","journal-title":"FEBS. Lett."},{"key":"10.1016\/j.neuint.2017.11.006_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2017.11.006_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainres.2007.01.131","article-title":"Nrf2-mediated protection against 6- hydroxydopamine","volume":"1144","author":"Jakel","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2017.11.006_bib25","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2017.11.006_bib26","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/WNL.66.10_suppl_4.S24","article-title":"The pathogenesis of cell death in Parkinson's disease","volume":"66","author":"Jenner","year":"2006","journal-title":"Neurol"},{"key":"10.1016\/j.neuint.2017.11.006_bib27","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/jm2016073","article-title":"A\u00a0synthetic chalcone as a potent inducer of glutathione biosynthesis","volume":"55","author":"Kachadourian","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuint.2017.11.006_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0306-4522(00)00077-4","article-title":"Enhanced vulnaerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation","volume":"97","author":"Kanda","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2017.11.006_bib29","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.1074\/jbc.M109.031575","article-title":"Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts","volume":"285","author":"Kapeta","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.11.006_bib30","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1046\/j.1471-4159.2003.01601.x","article-title":"Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in\u00a0vitro and following cerebral ischaemia in\u00a0vivo","volume":"84","author":"Kapinya","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2017.11.006_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1749-6632.2011.06092.x","article-title":"Regulation of the Keap1\/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modification","volume":"1229","author":"Keum","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuint.2017.11.006_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5607\/en.2013.22.2.77","article-title":"Alpha-synuclein expression in patients with Parkinson's disease: a clinician's perspective","volume":"22","author":"Kim","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.neuint.2017.11.006_bib33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2009.09.103","article-title":"Vertical grid test and modified horizontal grid test are sensitive methods for evaluating motor dysfunctions in the MPTP mouse model of Parkinson's disease","volume":"1306","author":"Kim","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2017.11.006_bib34","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.11.006_bib35","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1021\/jm2002348","article-title":"Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells","volume":"54","author":"Kumar","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuint.2017.11.006_bib36","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.freeradbiomed.2007.05.029","article-title":"Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells","volume":"43","author":"Kwak","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2017.11.006_bib37","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1128\/MCB.23.23.8786-8794.2003","article-title":"Antioxidants enhance mammalian proteasome expression through the keap1-Nrf2 signaling pathway","volume":"23","author":"Kwak","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuint.2017.11.006_bib38","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1074\/jbc.M211898200","article-title":"Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival","volume":"278","author":"Kwak","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.11.006_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2015.6549","article-title":"Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease","volume":"25","author":"Lastres-Becker","year":"2016","journal-title":"Antioxid. Redox. Signal"},{"key":"10.1016\/j.neuint.2017.11.006_bib40","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1093\/hmg\/dds143","article-title":"\u03b1-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease","volume":"21","author":"Lastres-Becker","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2017.11.006_bib41","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/bph.12973","article-title":"A\u00a0novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model","volume":"172","author":"Lee","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2017.11.006_bib42","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1080\/10715762.2016.1223293","article-title":"A\u00a0novel synthetic isothiocyanate ITC-57 displays antioxidant, anti-inflammatory, and neuroprotective properties in a mouse Parkinson's disease model","volume":"50","author":"Lee","year":"2016","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.neuint.2017.11.006_bib43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12640-015-9550-z","article-title":"A\u00a0novel compound ITC-3 activates the Nrf2 signaling and provides neuroprotection in Parkinson's disease models","volume":"28","author":"Lee","year":"2015","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuint.2017.11.006_bib44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.phrs.2008.03.004","article-title":"Bromocriptine activates NQO1 via Nrf2-PI3K\/Akt signaling: novel cytoprotective mechanism against oxidative damage","volume":"57","author":"Lim","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuint.2017.11.006_bib45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7150\/ijbs.8366","article-title":"Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson's disease induced by MPTP","volume":"10","author":"Lu","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuint.2017.11.006_bib46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/auto.8.1.18313","article-title":"Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy","volume":"8","author":"Lu","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.neuint.2017.11.006_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","article-title":"Altered proteasomal function in sporadic Parkinson's disease","volume":"179","author":"McNaught","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.11.006_bib48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2017.11.006_bib49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrd3430","article-title":"Priorities in Parkinson\u02bcs disease research","volume":"10","author":"Meissner","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuint.2017.11.006_bib50","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00702-004-0167-2","article-title":"Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress","volume":"111","author":"Mytilineou","year":"2004","journal-title":"J.\u00a0Neural. Transm. (Vienna)"},{"key":"10.1016\/j.neuint.2017.11.006_bib51","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.freeradbiomed.2010.02.024","article-title":"Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: modulation by the Nrf2\/Trx axis","volume":"48","author":"Niso-Santano","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2017.11.006_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s13318-016-0320-y","article-title":"Pharmacokinetic studies of oxathio-heterocycle fused chalcones","volume":"42","author":"Okoniewska","year":"2017","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.neuint.2017.11.006_bib53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1471-4906(03)00181-9","article-title":"Heme oxygenase-1: unleashing the protective properties of heme","volume":"24","author":"Otterbein","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neuint.2017.11.006_bib54","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-007-0332-4","article-title":"Curcumin inhibits aggregation of alpha-synuclein","volume":"115","author":"Pandey","year":"2008","journal-title":"Acta. Neuropathol."},{"key":"10.1016\/j.neuint.2017.11.006_bib55","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1021\/acs.orglett.6b03807","article-title":"De novo assembly of highly substituted morpholines and piperazines","volume":"19","author":"Patil","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.neuint.2017.11.006_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mam.2016.05.001","article-title":"Degradation of oxidized proteins by the proteasome: distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways","volume":"50","author":"Raynes","year":"2016","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.neuint.2017.11.006_bib57","first-page":"1777","article-title":"Emphasizing morpholine and its derivatives (MAID): typical candidate of pharmaceutical importance","volume":"14","author":"Rupak","year":"2016","journal-title":"Int. J. Chem. Sci."},{"key":"10.1016\/j.neuint.2017.11.006_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly sective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.11.006_bib59","doi-asserted-by":"crossref","first-page":"e1454","DOI":"10.3390\/ijms17091454","article-title":"Isothiocyanates are promising compounds against oxidative stress, neuroinflammation and cell death that may benefit neurodegeneration in Parkinson's disease","volume":"17","author":"Sita","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2017.11.006_bib60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12031-015-0516-7","article-title":"Induction of NQO1 and neuroprotection by a novel compound KMS04014 in Parkinson's disease models","volume":"56","author":"Son","year":"2015","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuint.2017.11.006_bib61","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1476-5381.2011.01692.x","article-title":"A\u00a0novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP","volume":"165","author":"Son","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2017.11.006_bib62","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2017.11.006_bib63","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nrn2499","article-title":"Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction","volume":"9","author":"Tai","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2017.11.006_bib64","doi-asserted-by":"crossref","first-page":"44405","DOI":"10.1074\/jbc.M308041200","article-title":"Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function","volume":"278","author":"Tofaris","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.11.006_bib65","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1021\/jm501100b","article-title":"Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals","volume":"57","author":"Vitaku","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuint.2017.11.006_bib66","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1073\/pnas.94.10.5361","article-title":"Functional antioxidant responsive elements","volume":"94","author":"Wasserman","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2017.11.006_bib67","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/jm401788m","article-title":"Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson's disease therapy","volume":"57","author":"Woo","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuint.2017.11.006_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-211-73574-9_9","article-title":"Luteolin protects rat PC12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway","author":"Wruck","year":"2007","journal-title":"J.\u00a0Neural. Transm. Suppl."},{"key":"10.1016\/j.neuint.2017.11.006_bib69","doi-asserted-by":"crossref","first-page":"e5757","DOI":"10.1371\/journal.pone.0005757","article-title":"Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription","volume":"4","author":"Yang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2017.11.006_bib70","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1073\/pnas.93.7.2696","article-title":"Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease","volume":"93","author":"Yoritaka","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2017.11.006_bib71","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.toxlet.2006.07.340","article-title":"Overexpression of NQO1 protects human SK-N-MC neuroblastoma cells against dopamine-induced cell death","volume":"166","author":"Zafar","year":"2006","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuint.2017.11.006_bib72","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease","volume":"19","author":"Zhang","year":"2005","journal-title":"Faseb. J."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018617304394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018617304394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T07:00:35Z","timestamp":1570345235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018617304394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":72,"alternative-id":["S0197018617304394"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2017.11.006","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}